The Fascinating Reason Why the Government Will Fund Research to Make Viruses Deadlier Again

December 20, 2017, 7:52 PM UTC
Image of Aids virus
Image of Aids virus from Uganda. World Health Organisation/Institut Pasteur (Photo by: Universal History Archive/UIG via Getty Images)
Universal History Archive UIG via Getty Images

Would you take a deadly pathogen like the influenza, SARS, or MERS virus and make it even deadlier? Well, the National Institute of Health (NIH) may, after a three-year hiatus, decide to fund your research. Which raises the question: Why?

The goal here is to “develop strategies and effective countermeasures against rapidly evolving pathogens that pose a threat to public health,” the NIH explains. That is, so-called “gain of function” research in pathogens may help scientists anticipate how viruses may spread and evolve, and therefore how to stop them from leading to unmanageable pandemics. The NIH’s funding pause on such studies went into effect in October 2014 but has now been lifted.

Click here to subscribe to Brainstorm Health Daily, our brand new newsletter about health innovations.

Still, the very idea likely sounds like a horror movie—which is why the NIH has listed out detailed criteria for what kind of lethal virus research would make the cut for government funding. “We have a responsibility to ensure that research with infectious agents is conducted responsibly, and that we consider the potential biosafety and biosecurity risks associated with such research,” said NIH director Dr. Francis Collins in a statement. “I am confident that the thoughtful review process laid out by the HHS P3CO Framework will help to facilitate the safe, secure, and responsible conduct of this type of research in a manner that maximizes the benefits to public health.”

For instance, the research would have to be both ethically and scientifically justified. You can’t just go around enhancing any old virus; it would have to be one that feasibly poses a threat to humans. And institutions involved in conducting such studies would have to prove they have the technology and protocols to carry it out safely.

Pandemics like the 2014 Ebola outbreak, or the wildfire spread of MERS, SARS, and flu are difficult to contain once they’ve already infiltrated human population centers—which is why global health experts have urged new research and incentive models to prevent pandemics from occurring in the first place. Making lethal viruses deadlier in a controlled setting could be one part of that effort, in the NIH’s eyes.

Subscribe to Well Adjusted, our newsletter full of simple strategies to work smarter and live better, from the Fortune Well team. Sign up today.

Read More

COVID VaccinesReturn to WorkMental Health